Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report

IJU Case Reports

Shingo Kamei¹  Koji Kameyama¹  Satoshi Ishihara¹  Shigeaki Yokoi¹  Manabu Takai¹  Takashi Deguchi¹  Shohei Toyota¹ 

[1] Department of Urology Kizawa Memorial Hospital Minokamo Gifu Japan;

关键词: epithelioid angiomyolipoma;    everolimus;    hemodialysis;    mammalian target of rapamycin inhibitors;    tuberous sclerosis;   

DOI  :  10.1002/iju5.12103

来源: DOAJ

【 摘 要 】

Introduction A patient undergoing hemodialysis and being treated with everolimus for metastatic epithelioid angiomyolipoma has never been described in the literature, to our knowledge. Case presentation A 53‐year‐old woman who had undergone trans‐arterial embolization for epithelioid angiomyolipoma was referred with a chief complaint about right knee pain. Hemodialysis had been started after the embolization. Needle biopsy specimens of tumors obtained from behind the right kidney and in the right femur were diagnosed as epithelioid angiomyolipoma metastases. The patient underwent treatment with everolimus and achieved a partial response after 6 months of treatment without serious adverse events. Conclusion Everolimus might be effective for patients with metastatic epithelioid angiomyolipoma who are undergoing hemodialysis.

【 授权许可】

Unknown